Charlie Hospital Semarang Tbk. vs Venteny Fortuna International Tbk. — how do they compare? Charlie Hospital Semarang Tbk. trades at Rp270 (market cap 742B, 29.45M 24h volume), while Venteny Fortuna International Tbk. trades at Rp69 (market cap 413.5B, 26.31M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is the larger of the two by market cap, and Charlie Hospital Semarang Tbk. is more actively traded (29.45M versus 26.31M). Which is the better fit depends on your goals.
| RSCH | VTNY | |
|---|---|---|
Market Cap | 742B | 413.5B |
Volume | 29.45M | 26.31M |
Lot | 294.49K | 263.09K |
Turnover | 8.14B | 1.79B |
Average Price | 276.35 | 67.87 |
Value | 8.14B | 1.79B |
Indicative Equilibrium Price | 270 | 69 |
Indicative Equilibrium Volume | 103 | 876 |
Trailing returns across standard periods
Latest headlines on both assets
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →PT Venteny Fortuna International Tbk (the Entity) was established based on Notarial Deed No. 7,dated January 29, 2021 of Anastasia Chandra, S.H., M.Kn., Notary in Tangerang. The Entity started its commercial operations in 2021. PT Venteny Fortuna International Tbk is the parent entity, whereas Junichiro Waide is the ultimate beneficial owner.
Read more on VTNY →